Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: Common, harmful, yet underappreciated

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 7, 2009, Pages 1012-1025

  Henriksen, Kammi J ^a   Meehan, Shane M ^a   Chang, Anthony ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; GEMCITABINE; MITOMYCIN C; RAPAMYCIN; SILVER; SORAFENIB; SUNITINIB; TEMSIROLIMUS; VINCRISTINE;

ANTIGEN ANTIBODY COMPLEX; ATHEROSCLEROSIS; CANCER SURVIVAL; CLINICAL FEATURE; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; EMBOLISM; FOCAL GLOMERULOSCLEROSIS; GLOMERULITIS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY CARCINOMA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUMOR; MEDICAL PRACTICE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHRECTOMY; NEPHROSCLEROSIS; NEPHROURETERECTOMY; PATHOGENESIS; PATHOLOGIST; PERIODIC ACID SCHIFF STAIN; PREECLAMPSIA; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REVIEW; SICKLE CELL ANEMIA; SILVER STAINING; THROMBOTIC THROMBOCYTOPENIC PURPURA; XANTHOGRANULOMATOUS PYELONEPHRITIS;

ADULT; DISEASE PROGRESSION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY NEOPLASMS; NEPHRECTOMY; URETER;

EID: 67649984596     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. College of American Pathologists. Cancer protocols and checklists. http:// www.cap.org/apps/cap.portal?-nfpb-true&cntvwrPtlt-actionOverride= %2Fportlets%2FcontentViewer%2Fshow&-windowLabel=cntvwrPtlt&cntvwrPtlt% 7BactionForm.contentReference%7D=committees%2Fcancer%2Fcancer- protocols%2Fprotocols-index.html&-state-maximized&-pageLabel-cntvwr. Updated January 2005. Accessed June 28, 2008.
2. Association of Directors of Anatomic and Surgical Pathology. Checklists and guidelines for surgical pathology reports of malignant neoplasms. http://www.adasp. org/Checklists/checklists.htm. Updated November 2003. Accessed June 27, 2008.
3. Henriksen KJ, Meehan SM, Chang A. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases. Am J Surg Pathol. 2007;31:1703-1708. (Pubitemid 350287568)
4. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
5. St Peter WL. Introduction: chronic kidney disease: a burgeoning health epidemic. J Manag Care Pharm. 2007;13:S2-S5. (Pubitemid 351166378)
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305. (Pubitemid 39268908)
7. Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005;16:3728-3735. (Pubitemid 46211295)
8. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735-740. (Pubitemid 44283660)
9. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000; 75:1236-1242.
10. Choi MY, Jee SH, Sull JW, Nam CM. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int. 2005;67:647-652. (Pubitemid 40139856)
11. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343:1305-1311. (Pubitemid 30808125)
12. Kirchner FK Jr. Incidence of renal cell carcinoma with hypertension. J Urol. 1978;119:579.
13. Melman A, Grim CE, Weinberger MH. Increased incidence of renal cell carcinoma with hypertension. J Urol. 1977;118:531-532. (Pubitemid 8227389)
14. Zucchetto A, Dal Maso L, Tavani A, et al. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Ann Oncol. 2007;18:596-600. (Pubitemid 46359645)
15. Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nose V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006;30:575-584. (Pubitemid 44265009)
16. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol. 2002;167:57-60. (Pubitemid 34024497)
17. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113:78-83. (Pubitemid 351976389)
18. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 2000;163:1090-1095; quiz 1295.
19. Bolenz C, Fernandez MI, Trojan L, et al. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology. 2008;72:364-369.
20. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2005;45:A5-A7,S1-S280.
21. Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D'AgatiVD. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70:2148-2151. (Pubitemid 44871379)
22. van der Ven K, Nguyen TQ, Goldschmeding R. Immunofluorescence on proteinase XXIV-digested paraffin sections. Kidney Int. 2007;72:896. (Pubitemid 47462084)
23. Collar J, Cattell V. Paraffin-processed material is unsuitable for diagnosis of thin-membrane disease. Nephron. 1995;69:187-188.
24. Nasr SH, Markowitz GS, Valeri AM, Yu Z, Chen L, D'Agati VD. Thin basement membrane nephropathy cannot be diagnosed reliably in deparaffinized, formalin-fixed tissue. Nephrol Dial Transplant. 2007;22:1228-1232. (Pubitemid 46523443)
25. Miller K. Immunohistochemistry on renal biopsies. http://www. renalpathsoc.org/pg9pathforBoards/Millerpaper.HTM. Updated October 16, 1996. Accessed June 26, 2008.
26. Howie AJ, Gregory J, Thompson RA, Adkins MA, Niblett AJ. Technical improvements in the immunoperoxidase study of renal biopsy specimens. J Clin Pathol. 1990;43:257-259. (Pubitemid 20087581)
27. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18: 2644-2648. (Pubitemid 47531190)
28. Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999;42:107-112. (Pubitemid 29039747)
29. Hepps D, Chernoff A. Risk of renal insufficiency in African-Americans after radical nephrectomy for kidney cancer. Urol Oncol. 2006;24:391-395. (Pubitemid 44311553)
30. Alpers CE, Biava CG. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity. Clin Nephrol. 1989;32:68-74. (Pubitemid 19204967)
31. Markowitz GS, Lin J, Valeri AM, Avila C, Nasr SH, D'Agati VD. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol. 2002;33:826-835. (Pubitemid 34983104)
32. Bilous RW, Mauer SM, Sutherland DE, Najarian JS, Goetz FC, Steffes MW. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med. 1989;321:80-85. (Pubitemid 19170396)
33. Shirasaki Y, Tsushima T, Nasu Y, Kumon H. Long-term consequence of renal function following nephrectomy for renal cell cancer. Int J Urol. 2004;11:704-708. (Pubitemid 39387515)
34. Kwaan HC, Gordon LI. Thrombotic microangiopathy in the cancer patient. Acta Haematol. 2001;106:52-56. (Pubitemid 32830516)
35. Levi M. Cancer and thrombosis. Clin Adv Hematol Oncol. 2003;1:668-671.
36. Nadir Y, Hoffman R, Brenner B. Drug-related thrombosis in hematologic malignancies. Rev Clin Exp Hematol. 2004;8:E4. (Pubitemid 40944895)
37. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125-134. (Pubitemid 46089673)
38. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115-124. (Pubitemid 46089672)
39. Patel TV, Morgan JA, Demetri GD, et al. A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib. J Natl Cancer Inst. 2008;100:282-284.
40. Khurana A. Allergic interstitial nephritis possibly related to sunitinib use. Am J Geriatr Pharmacother. 2007;5:341-344.
41. Frangie C, Lefaucheur C, Medioni J, Jacquot C, Hill GS, Nochy D. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol. 2007;8:177-178. (Pubitemid 46158384)
42. Roncone D, Satoskar A, Nadasdy T, Monk JP, Rovin BH. Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol. 2007;3:287-293. (Pubitemid 46674523)
43. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129-1136.
44. Barone GW, Gurley BJ, Abul-Ezz SR, Gokden N. Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient. Am J Kidney Dis. 2003;42: 202-206. (Pubitemid 36807670)
45. Crew RJ, Radhakrishnan J, Cohen DJ, et al. De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases. Nephrol Dial Transplant. 2005;20:203-209. (Pubitemid 40207628)
46. Smith KD, Wrenshall LE, Nicosia RF, et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol. 2003;14:1037-1045. (Pubitemid 36359286)
47. Pelletier R, Nadasdy T, Nadasdy G, et al. Acute renal failure following kidney transplantation associated with myoglobinuria in patients treated with rapamycin. Transplantation. 2006;82:645-650. (Pubitemid 44395234)
48. Margulis V, Matin SF, Tannir N, et al. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol. 2008;180:94-98.
49. Dimashkieh H, Choe J, Mutema G. Renal medullary carcinoma: a report of 2 cases and review of the literature. Arch Pathol Lab Med. 2003;127:e135-e138.
50. Bakir AA, Hathiwala SC, Ainis H, et al. Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am J Nephrol. 1987;7: 110-115. (Pubitemid 17094643)
51. Nasr SH, Markowitz GS, Sentman RL, D'Agati VD. Sickle cell disease, nephrotic syndrome, and renal failure. Kidney Int. 2006;69:1276-1280.
52. Dictor M, Hasserius R. Systemic amyloidosis and non-hematologic malignancy in a large autopsy series. Acta Pathol Microbiol Scand [A]. 1981;89:411-416. (Pubitemid 12194358)
53. Vanatta PR, Silva FG, Taylor WE, Costa JC. Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature.Hum Pathol. 1983;14:195-201.
54. Azzopardi JG, Lehner T. Systemic amyloidosis and malignant disease. J Clin Pathol. 1966;19:539-548.
55. Ersoy A, Filiz G, Ersoy C, et al. Synchronous carcinomas of stomach and bladder together with AA amyloidosis. Nephrology (Carlton). 2006;11:120-123.
56. Somer TP, Tornroth TS. Renal adenocarcinoma and systemic amyloidosis. Immunohistochemical and histochemical studies. Arch Pathol Lab Med. 1985; 109:571-574 (Pubitemid 15032599)
57. Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B. Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int. 2008;74:218-222. (Pubitemid 351915083)
58. Toyoda M, Kudo M, Ebihara Y. Amyloid deposition in renal angiomyolipoma. Pathol Int. 1999;49:180-184. (Pubitemid 29133481)
59. Karsenty G, Ulmann A, Droz D, Carnot F, Grunfeld JP. Clinical and histological resolution of systemic amyloidosis after renal cell carcinoma removal. Nephron. 1985;40:232-234. (Pubitemid 15064580)
60. Lowenstein J, Gallo G. Remission of the nephrotic syndrome in renal amyloidosis. N Engl J Med. 1970;282:128-132.
61. Bjorneklett R, Vikse BE, Svarstad E, et al. Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis. 2007;50:396-403. (Pubitemid 47285451)
62. Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5-10. (Pubitemid 23203492)
63. Eagen JW. Glomerulopathies of neoplasia. Kidney Int. 1977;11:297-303. (Pubitemid 8119703)
64. Lee JC, Yamauchi H, Hopper J Jr. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41-51.
65. Lefaucheur C, Stengel B, Nochy D, et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006;70:1510-1517. (Pubitemid 44527323)
66. Cudkowicz ME, Sayegh MH, Rennke HG. Membranous nephropathy in a patient with renal cell carcinoma. Am J Kidney Dis. 1991;17:349-351.
67. Fujita Y, Kashiwagi T, Takei H, et al. Membranous nephropathy complicated by renal cell carcinoma. Clin Exp Nephrol. 2004;8:59-62. (Pubitemid 38508657)
68. Kapoulas S, Liakos S, Karkavelas G, Grekas D, Giannoulis E. Membranous glomerulonephritis associated with renal cell carcinoma. Clin Nephrol. 2004;62: 476-477. (Pubitemid 39654589)
69. Kerpen HO, Bhat JG, Feiner HD, Baldwin DS. Membranous nephropathy associated with renal cell carcinoma. Evidence against a role of renal tubular or tumor antibodies in pathogenesis. Am J Med. 1978;64:863-867. (Pubitemid 8328137)
70. Kuroda I, Ueno M, Okada H, et al. Nephrotic syndrome as a result of membranous nephropathy caused by renal cell carcinoma. Int J Urol. 2004;11: 235-238. (Pubitemid 38560329)
71. Nishibara G, Sukemi T, Ikeda Y, Tomiyoshi Y. Nephrotic syndrome due to membranous nephropathy associated with renal cell carcinoma. Clin Nephrol. 1996;45:424. (Pubitemid 26187148)
72. Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574-579. (Pubitemid 38263115)
73. Stein HD, Yudis M, Sirota RA, Snipes ER, Gronich JH. Membranous nephropathy associated with renal cell carcinoma. Am J Kidney Dis. 1993;22:352. (Pubitemid 23236647)
74. Togawa A, Yamamoto T, Suzuki H, et al. Membranous glomerulonephritis associated with renal cell carcinoma: failure to detect a nephritogenic tumor antigen. Nephron. 2002;90:219-221. (Pubitemid 34702001)
75. Haas M. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis. 1994;23:358-364. (Pubitemid 24081373)
76. Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ. Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med. 1974;57:962-970.
77. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int. 1986; 30:465-473. (Pubitemid 16000790)
78. Ozawa T, Pluss R, Lacher J, et al. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes. Q J Med. 1975;44:523-541.
79. Yamauchi H, Linsey MS, Biava CG, Hopper J Jr. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med. 1985;145:2061-2063. (Pubitemid 16198407)
80. Nair R, Walker PD. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int. 2006;69:1455-1458.
81. Beaufils H, Patte R, Aubert P, et al. Renal immunopathology in renal cell carcinoma. Virchows Arch A Pathol Anat Histopathol. 1984;404:87-97. (Pubitemid 14095252)
82. Magyarlaki T, Kiss B, Buzogany I, Fazekas A, Sukosd F, Nagy J. Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron. 1999;82:127-130. (Pubitemid 29263971)
83. Abu-Romeh SH, al-Adnani MS, Asfar S. Renal cell carcinoma presenting with acute renal failure and IgA glomerulonephritis. Nephron. 1988;50:169-170.
84. Tanaka K, Kanzaki H, Taguchi T. IgA glomerulonephritis in a patient with renal cell carcinoma. Nippon Jinzo Gakkai Shi. 1991;33:87-90.
85. Sessa A, Volpi A, Tetta C, et al. IgA mesangial nephropathy associated with renal cell carcinoma. Appl Pathol. 1989;7:188-191. (Pubitemid 19188725)
86. Jain S, Kakkar N, Joshi K, Varma S. Crescentic glomerulonephritis associated with renal cell carcinoma. Ren Fail. 2001;23:287-290. (Pubitemid 32523861)
87. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829-842. (Pubitemid 27251835)
88. Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L. Hepatitis C virus-related kidney disease: an overview. Clin Nephrol. 2008;69:149-160. (Pubitemid 351351061)
89. Da'as N, Polliack A, Cohen Y, et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol. 2001;67:158-164. (Pubitemid 33105055)
90. Heaton JM, Menzin MA, Carney DN. Extrarenal malignancy and the nephrotic syndrome. J Clin Pathol. 1975;28:944-946.
91. Usalan C, Emri S. Membranoproliferative glomerulonephritis associated with small cell lung carcinoma. Int Urol Nephrol. 1998;30:209-213. (Pubitemid 28459644)
92. Enriquez R, Sirvent AE, Cabezuelo JB, Perez-Ramos M, Amoros F, Reyes A. Membranoproliferative glomerulonephritis and gastric adenocarcinoma. Nephrol Dial Transplant. 1999;14:242-243. (Pubitemid 29041913)
93. Pascal RR, Finney RP, Rifkin SI, Kahana L. Glomerulonephritis and viruslike particles associated with prostatic cancer. Hum Pathol. 1980;11:391-399. (Pubitemid 10032511)
94. Reshi AR, Mir SA, Gangoo AA, Shah S, Banday K. Nephrotic syndrome associated with transitional cell carcinoma of urinary bladder. Scand J Urol Nephrol. 1997;31:295-296. (Pubitemid 27293676)
95. Tydings A, Weiss RR, Lin JH, Bennett J, Tejani N. Renal-cell carcinoma and mesangiocapillary glomerulonephritis presenting as severe pre-eclampsia. N Y State J Med. 1978;78:1950-1954. (Pubitemid 9032067)
96. Ahmed M, Solangi K, Abbi R, Adler S. Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis. J Am Soc Nephrol. 1997;8:848-852. (Pubitemid 27493600)
97. Thorner P, McGraw M, Weitzman S, Balfe JW, Klein M, Baumal R.Wilms' tumor and glomerular disease. Occurrence with features of membranoproliferative glomerulonephritis and secondary focal, segmental glomerulosclerosis. Arch Pathol Lab Med. 1984;108:141-146. (Pubitemid 14181715)
98. Sethi S, Sahani M, Oei LS, Rao R. Crescentic glomerulonephritis and dense deposit disease in a woman with breast carcinoma on immunosuppressive chemotherapy. Am J Kidney Dis. 2004;44:e33-e7. (Pubitemid 39164611)
99. Dussol B, Brunet P,Vacher-Coponat H, Bouabdallah R, Chetaille P, Berland Y. Crescentic glomerulonephritis with antineutrophil cytoplasmic antibodies associated with chronic lymphocytic leukaemia. Nephrol Dial Transplant. 1997;12: 785-786. (Pubitemid 27170439)
100. Pamuk GE, Uyanik MS, Demir M, Tekgunduz E, Turgut B, Soy M. Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia: quite a rare diagnosis. Leuk Res. 2007;31:1149-1151. (Pubitemid 46873719)
101. Hruby Z, Bronowicz A, Rabczynski J, KopecW, Szewczyk Z. A case of severe anti-neutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis and asymptomatic gastric cancer. Int Urol Nephrol. 1994;26:579-586. (Pubitemid 24357304)
102. Baschinsky DY, Baker PB, Niemann TH, Wilmer WA. Pauci-immune ANCA-positive crescentic glomerulonephritis associated with metastatic adenocarcinoma of the lung. Am J Kidney Dis. 2000;36:E24.
103. Edgar JD, Rooney DP, McNamee P, McNeill TA. An association between ANCA positive renal disease and malignancy. Clin Nephrol. 1993;40:22-25. (Pubitemid 23221729)
104. von Vietinghoff S, Schneider W, Luft FC, Kettritz R. Crescentic glomerulonephritis and malignancy-guilty or guilt by association? Nephrol Dial Transplant. 2006;21:3324-3326. (Pubitemid 44567116)
105. Karim MY, Frankel A, Paradinas FJ, Moss J. Anti-neutrophil cytoplasmic antibody-positive crescentic nephritis occurring together with renal cell carcinoma. Nephron. 2000;85:368-370. (Pubitemid 30665873)
106. Whitworth JA, Morel-Maroger L, Mignon F, Richet G. The significance of extracapillary proliferation. Proc Eur Dial Transplant Assoc. 1975;11:522-525.
107. Tatsis E, Reinhold-Keller E, Steindorf K, Feller AC, Gross WL. Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum. 1999;42: 751-756. (Pubitemid 29171996)
108. Villa-Forte A, Hoffman GS. Wegener's granulomatosis presenting with a renal mass. J Rheumatol. 1999;26:457-458. (Pubitemid 29066757)
109. Norris JH, Leeds J, Jeffrey RF. P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. Ren Fail. 2003;25:311-314. (Pubitemid 36529674)
110. Lloyd M, de Verteuil J, Andrews PA. Renal vasculitis associated with renal cell carcinoma. J R Soc Med. 2002;95:305-306. (Pubitemid 34666513)
111. Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol. 1995;5:1740-1744.
112. Kai H, Yamagata K, Usui J, et al. Crescentic glomerulonephritis associated with renal cell carcinoma after cancer immunotherapy. J Nephrol. 2005;18:436-441. (Pubitemid 41700109)
113. Feriozzi S, Giannakakis K, Ranalli TV, Pofi E, Gomes V, Ancarani E. Renal oncocytoma associated with necrotizing glomerulonephritis. Ren Fail. 2006;28: 181-183.
114. D'Agati VD, Jennette JC, Silva FG. Non-Neoplastic Kidney Diseases. Silver Spring, MD: ARP Press; 2005:394.
115. Roussou M, Dimopoulos SK, Dimopoulos MA, Anastasiou-Nana MI. Wegener's granulomatosis presenting as a renal mass. Urology. 2008;71:547 e1-e2.
116. Vandergheynst F, Van Gansbeke D, Cogan E. Wegener's granulomatosis masquerading as a renal cancer: a case report and review of the literature. Clin Exp Rheumatol. 2006;24:584-586. (Pubitemid 44911256)
117. Hatakeyama S, Kawano M, Konosita T, et al. A case of renal cell carcinoma associated with rapidly progressive glomerulonephritis. Nippon Jinzo Gakkai Shi. 1990;32:1125-1132.
118. Susman BR, Levin FC, Barland P, Fromowitz F. Vasculitis; associated with renal oncocytoma. N Y State J Med. 1981;81:1501-1503.
119. Hoag GN. Renal cell carcinoma and vasculitis: report of two cases. J Surg Oncol. 1987;35:35-38. (Pubitemid 17075287)
120. Haas M, Spargo BH, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis. 1995;26:740-750.
121. Ejaz AA, Geiger XJ, Wasiluk A. Focal segmental glomerulosclerosis in kidney resected for renal cell carcinoma. Int Urol Nephrol. 2005;37:345-349. (Pubitemid 41349203)
122. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004; 43:368-382. (Pubitemid 38146337)
123. D'Agati VD. The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens. 2008;17:271-281.
124. Forland M, Bannayan GA. Minimal-change lesion nephrotic syndrome with renal oncocytoma. Am J Med. 1983;75:715-720.
125. Auguet T, Lorenzo A, Colomer E, et al. Recovery of minimal change nephrotic syndrome and acute renal failure in a patient with renal cell carcinoma. Am J Nephrol. 1998;18:433-435. (Pubitemid 28442109)
126. Martinez-Vea A, Panisello JM, Garcia C, et al. Minimal-change glomerulopathy and carcinoma. Report of two cases and review of the literature. Am J Nephrol. 1993;13:69-72. (Pubitemid 23137635)
127. Beisland C, Talleraas O, Bakke A, Norstein J. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int. 2006;97:698-702. (Pubitemid 43383497)
128. Rabbani F, Reuter VE, Katz J, Russo P. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology. 2000; 56:399-403. (Pubitemid 30658167)
129. Kunthur A, Wiernik PH, Dutcher JP. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature. Am J Hematol. 2006;81:271-280.
130. Kiely JM, Wagoner RD, Holley KE. Renal complications of lymphoma. Ann Intern Med. 1969;71:1159-1175.
131. Sullu Y, Donmez G, Kandemir B, Gun S. Renal cell carcinoma with non- Hodgkin's lymphoma infiltration: a case report. Pathol Res Pract. 2007;203:625-627. (Pubitemid 47163504)
132. Nishikubo CY, Kunkel LA, Figlin R, et al. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients. Cancer. 1996;78:2421-2426. (Pubitemid 26392843)
133. Anderson CM, Pusztai L, Palmer JL, Cabanillas F, Ellerhorst JA. Coincident renal cell carcinoma and nonHodgkin's lymphoma: the M. D. Anderson experience and review of the literature. J Urol. 1998;159:714-717. (Pubitemid 28106509)
134. Wang BY, Strauchen JA, Rabinowitz D, Tillem SM, Unger PD. Renal cell carcinoma with intravascular lymphomatosis: a case report of unusual collision tumors with review of the literature. Arch Pathol Lab Med. 2001;125:1239-1241. (Pubitemid 32845807)
135. Jimenez VH. Coexistence between renal cell cancer and Hodgkin's lymphoma: a rare coincidence. BMC Urol. 2006;6:10.
136. Radin DR, Chandrasoma P. Coexistent xanthogranulomatous pyelonephritis and renal cell carcinoma. J Comput Tomogr. 1987;11:294-296 (Pubitemid 17130172)
137. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149-1160. (Pubitemid 47207116)
138. Papadopoulos I, Wirth B, Wand H. Xanthogranulomatous pyelonephritis associated with renal cell carcinoma. Report on two cases and review of the literature. Eur Urol. 1990;18:74-76. (Pubitemid 20226696)
139. Val-Bernal JF, Castro F. Xanthogranulomatous pyelonephritis associated with transitional cell carcinoma of the renal pelvis. Urol Int. 1996;57:240-245. (Pubitemid 26402435)
140. Bottalico T, Parks S, Zaslau S, Tarry WF. Pediatric xanthogranulomatous pyelonephritis masquerading as complex renal mass. Urology. 2007;70:372.e11-e12. (Pubitemid 47362272)
141. Mittal BV, Pendse S, Rennke HG, Singh AK. Hematuria in a patient with class IV lupus nephritis. Kidney Int. 2006;70:1182-1186. (Pubitemid 44344091)
142. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63:1450-1461. (Pubitemid 36350010)
143. Ng CS, Gill IS. Impact of renal cryoablation on urine composition. Urology. 2002;59:831-834. (Pubitemid 34522169)
144. Stefanovic V, Radovanovic Z. Balkan endemic nephropathy and associated urothelial cancer. Nat Clin Pract Urol. 2008;5:105-112. (Pubitemid 351248099)
145. Chen CY, Liao YM, Tsai WM, Kuo HC. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease. J Formos Med Assoc. 2007;106:992-998.
146. Handa SP, Tewari HD. Urinary tract carcinoma in patients with analgesic nephropathy. Nephron. 1981;28:62-64. (Pubitemid 11003838)
147. Moshakis V, Hooper AA. Analgesic nephropathy and transitional cell carcinoma. Postgrad Med J. 1978;54:285-286. (Pubitemid 8340964)
148. Lornoy W, Becaus S, de Vleeschouwer M, et al. Renal cell carcinoma, a new complication of analgesic nephropathy. Lancet. 1986;1:1271-1272. (Pubitemid 16112323)
149. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol. 1994;25:22-28. (Pubitemid 24051820)
150. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153. (Pubitemid 43740182)